Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis

PLoS One. 2014 Apr 15;9(4):e93001. doi: 10.1371/journal.pone.0093001. eCollection 2014.

Abstract

It was found that high-affinity anti-DNA antibodies were one of the major components of the intrathecal IgG response in multiple sclerosis (MS) patients [Williamson et al., PNAS, 2001]. Recently we have shown that IgGs from the sera of MS patients are active in the hydrolysis of DNA. Here we have shown, for the first time, that average concentration of total proteins (132-fold), total IgGs (194-fold) and anti-DNA antibodies (200-fold) in the sera is significantly higher than that in the cerebrospinal fluid (CSF) of fifteen MS patients. The relative activities of total protein from sera and CSFs varied remarkably from patient to patient. It was surprising that the specific DNase activity of the total protein of CSF reparations were 198-fold higher than the serum ones. Electrophoretically and immunologically homogeneous IgGs were obtained by sequential affinity chromatography of the CSF proteins on protein G-Sepharose and FPLC gel filtration. We present first evidence showing that IgGs from CSF not only bind but efficiently hydrolyze DNA and that average specific DNase activity of homogeneous antibodies from CSF is unpredictably ∼49-fold higher than that from the sera of the same MS patients. Some possible reasons of these findings are discussed. We suggest that DNase IgGs of CSF may promote important neuropathologic mechanisms in this chronic inflammatory disorder and MS pathogenesis development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Antinuclear / blood*
  • Antibodies, Antinuclear / cerebrospinal fluid*
  • Antibodies, Antinuclear / immunology
  • Antibodies, Catalytic / blood*
  • Antibodies, Catalytic / cerebrospinal fluid*
  • Antibodies, Catalytic / immunology
  • DNA / chemistry
  • DNA / metabolism
  • Female
  • Humans
  • Hydrolysis
  • Immunoglobulin G / blood
  • Immunoglobulin G / cerebrospinal fluid
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • Multiple Sclerosis / blood*
  • Multiple Sclerosis / cerebrospinal fluid*
  • Multiple Sclerosis / immunology

Substances

  • Antibodies, Antinuclear
  • Antibodies, Catalytic
  • Immunoglobulin G
  • DNA

Grants and funding

This study was supported in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.2; Russian Foundation for Basic Research (13-04-00208, 13-04-00205, and 14-04-31281), funds from the Siberian Division of the Russian Academy of Sciences and funds from the Regione Emilia Romagna, Italy (Ricerca Sanitaria Finalizzata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.